Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) Stock Short Interest Report for October

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) was the target of a large decrease in short interest during the month of October. As of October 15th, there was short interest totaling 53 shares, a decrease of 89.9% from the September 30th total of 526 shares. Based on an average daily trading volume, of 5,493 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

Orion OYJ Stock Performance

ORINY stock traded up $1.73 during mid-day trading on Monday, hitting $55.85. 1,608 shares of the company were exchanged, compared to its average volume of 1,287. The business has a 50 day simple moving average of $46.72 and a 200-day simple moving average of $41.92. The company has a current ratio of 2.64, a quick ratio of 1.48 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $15.76 billion, a PE ratio of 22.98 and a beta of 0.07. Orion OYJ has a 1-year low of $30.89 and a 1-year high of $55.85.

About Orion OYJ

Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes prescription medicines, over-the-counter products, generic pharmaceuticals and active pharmaceutical ingredients.

The company focuses on several therapeutic areas, including central nervous system disorders, oncology, respiratory diseases, pain management and veterinary medicine. Orion is particularly recognized for treatments related to Parkinson’s disease, as well as its Easyhaler line of inhaled medicines for respiratory conditions.

Founded in Finland in 1917, Orion is headquartered in Espoo.